Difference between revisions of "ACS Infect Dis"
From Bioblast
(Created page with "{{Journal |Title=[https://pubs.acs.org/journal/aidcbc ACS Infectious Disease] }}}") Β |
|||
Line 1: | Line 1: | ||
{{Journal | {{Journal | ||
|Title=[https://pubs.acs.org/journal/aidcbc ACS Infectious | |Title=[https://pubs.acs.org/journal/aidcbc ACS Infectious Diseases] | ||
}}} | }} | ||
} |
Revision as of 09:21, 28 January 2019
Journal title and website | ACS Infectious Diseases |
---|
Publications
Reference | Published | View | |
---|---|---|---|
Lu 2018 ACS Infect Dis | Lu X, Williams Z, Hards K, Tang J, Cheung CY, Aung HL, Wang B, Liu Z, Hu X, Lenaerts AJ, Woolhiser L, Hastings C, Zhang X, Wang Z, Rhee KY, Ding K, Zhang T, Cook GM (2018) A pyrazolo[1,5-a]pyridine inhibitor of the respiratory cytochrome bcc complex for the treatment of drug-resistant tuberculosis. ACS Infect Dis 5:239-49. | 2018 | PMID: 30485737 |
}